Frazor Edmondson
Fortune : 559 553 $ au 30/06/2026
Fortune : 559 553 $ au 30/06/2026
Frazor Titus Edmondson currently works at Zai Lab Ltd., as Secretary & Chief Legal Officer from 2025.
Mr. Edmondson also formerly worked at Sumitomo Pharma America, Inc., as Secretary, Associate General Counsel & VP and Biogen, Inc., as Chief Corporation Counsel & Senior Vice President from 2014 to 2020.
Mr. Edmondson received his undergraduate degree in 1988 from Washington & Lee University and graduate degree in 1993 from Widener University School of Law.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZAI LAB LTD. 0,03 % | 26/06/2026 | 303 460 ( 0,03 % ) | 559 553 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ZAI LAB LIMITED | Conseiller Juridique Général | 07/08/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/08/2020 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Secrétaire Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Widener University School of Law
Widener University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national